Dr. TJ Mundheim, DCMost articles about the first month on GLP-1 medication focus exclusively on the medication. Here is what it will feel like, what the side effects are, how much weight you will lose in week one. That information is useful — I will cover all of it. But it misses the most important part of what is happening in Month 1 if you are doing this through the My4MLife 4M protocol.
The medication is not the whole story. Month 1 is simultaneously Week 1 through Week 4 of the 4M Cohort App protocol: gut repair, sleep architecture optimization, hormone foundation, and cognitive baseline. The medication creates a metabolic window — appetite suppression, caloric deficit, reduction in systemic inflammation — and the protocol builds real systemic change inside that window. The medication without the protocol produces weight loss that often reverses. The protocol with the medication produces a physiological reset that compounds over four months.
Here is what both look like in practice.
Week 1: Getting Started — Medication and Gut Foundation
First Injection + Gut-Repair Launch
Your first week begins with the lowest therapeutic dose. Semaglutide starts at 0.25 mg; tirzepatide starts at 2.5 mg. These doses are intentionally conservative — the goal is to let your gut adapt to the hormonal signal before escalating.
During the first few days, most patients notice subtle appetite changes: less interest in food between meals, quicker satiety, quieter cravings. Some patients notice nothing yet at week 1, which is also normal. The medication is building systemic levels; effects intensify over the first month.
In the 4M Cohort App, Week 1 launches the gut-repair module. The gut-brain axis is not a metaphor — it is a functional communication highway. The vagus nerve connects gut enteroendocrine cells directly to brainstem and limbic structures. A compromised gut microbiome drives systemic LPS (lipopolysaccharide) translocation, which is a significant contributor to the neuroinflammatory burden we are working to reduce. Week 1 in the app addresses this directly with the Biome NS Ultra protocol: L-Glutamine, DGL, Berberine, Aloe, Curcumin, Zinc Carnosine + A/D3 — the foundational gut-brain seal stack, with optional Biome NS Rx (compounded oral BPC-157 + L-Glutamine + Aloe triple-action stack) added for members on the deeper-repair tier.
What to expect physically: Mild nausea is the most commonly reported early side effect, occurring in roughly 40–45% of patients at some point in the first month. If it appears in week 1, it is typically mild and resolves within a few days. Staying hydrated and eating smaller, lower-fat meals helps significantly.
Week 2: Adjustment Phase — GI Stabilization and Sleep Protocol
Side Effects Peak, Then Stabilize
Week 2 brings your second injection at the same starting dose. For most patients, this is when GI side effects — if they are going to appear — become most noticeable as the medication reaches a more consistent systemic level. Nausea, mild bloating, or loose stool are the most common complaints. These are temporary and improve as the body adapts.
The hunger changes become more consistent in week 2. Food noise — the background mental chatter about eating and cravings — begins to quiet. Many patients describe a genuinely new relationship with hunger: it becomes a signal rather than a compulsion. This is the GLP-1 mechanism acting on hypothalamic appetite centers, not just stomach fullness.
In the app, Week 2 opens the sleep optimization module. Sleep architecture is one of the most underrated levers in cognitive longevity and metabolic health. Cortisol dysregulation from chronic poor sleep drives visceral fat deposition — which directly counteracts what the medication is trying to accomplish. Sleep debt also impairs glymphatic clearance, the brain's waste-removal system that runs primarily during deep sleep. The 4M sleep protocol addresses sleep pressure, circadian anchoring, and the specific cortisol-sleep loop that affects men disproportionately.
Scale progress week 2: Most patients see 1–3 lbs of movement in the first two weeks. Do not benchmark against that number — this is a physiological reset, not a weigh-in competition.
Week 3: Building Momentum — Hunger Shifts and Hormone Foundation
The Appetite Shift Becomes Real
Week 3 is where most patients experience what I call the "threshold moment" — a meaningful, unmistakable reduction in baseline hunger. Portions that previously felt normal now feel too large. The mental overhead around food drops significantly. This is not willpower. This is the medication restoring the hypothalamic signaling that was disrupted by years of excess visceral fat and insulin resistance.
Use this window deliberately. Because the appetite suppression is now reliable, you can be intentional about food quality without fighting hunger. Prioritize lean protein (60–80g daily minimum), anti-inflammatory vegetables, and whole food carbohydrates. Avoid high-fat, high-glycemic foods — they are harder on the GI system and work against the insulin sensitization the medication is building.
In the app, Week 3 introduces the hormone foundation module. Testosterone, cortisol, thyroid function, and insulin are tightly interdependent axes. Excess visceral fat suppresses testosterone through aromatization (converting testosterone to estrogen in fat tissue) and drives cortisol dysregulation. As visceral fat begins to reduce, this hormonal suppression lifts — but it needs support to normalize properly. The app module covers the nutritional, lifestyle, and supplement inputs that support hormonal restoration alongside the metabolic changes the medication is driving.
Week 4: First Check-In — Dose Escalation and Cognitive Baseline
Prescriber Review and the Cognitive Foundation
At the four-week mark, you will check in with your contracted licensed telemedicine provider. This review covers your response to the starting dose, side effect experience, weight movement, and readiness to escalate. By week 4, most patients have lost 3–6 pounds, though individual variation is wide — patients starting at higher body weights often lose more in month 1, while some respond more gradually and accelerate in months 2 and 3.
Your prescriber will evaluate whether to increase the dose. The titration schedule is typically every four weeks, with dose increases continuing until you reach the maintenance dose that produces consistent fat loss without intolerable side effects. More dose is not always better — the goal is the dose that works for your biology, not the maximum dose the protocol allows.
In the app, Week 4 completes the cognitive baseline assessment. This is the starting point for tracking cognitive function over the four-month protocol. We are measuring working memory, processing speed, and cognitive load tolerance — because these metrics, not just weight, are what we care about improving. The visceral fat reduction happening during month 1 has already begun to reduce the neuroinflammatory burden. The cognitive baseline gives us a documented before-state to measure against at months 2, 3, and 4.
Managing Side Effects: The Practical Toolkit
GI side effects are the primary reason people discontinue GLP-1 medication. They are largely avoidable or manageable with the right approach:
- Nausea: Eat smaller portions at each meal. Avoid lying down within two hours of eating. Low-fat, bland foods (lean protein, rice, cooked vegetables) are better tolerated during titration. Ginger — tea, capsules, or raw — has meaningful anti-nausea evidence and is included in the 4M supplement stack.
- Constipation: GLP-1 medications slow gastric motility. Target 64+ ounces of water daily. Gradually increase dietary fiber. Walking 20–30 minutes daily stimulates peristalsis more effectively than most supplements.
- Fatigue: Common in weeks 1–2 as the body adjusts to reduced caloric intake and hormonal shifts. Prioritize 7–9 hours of sleep (the Week 2 protocol addresses this directly), maintain adequate protein intake, and stay hydrated. Fatigue typically resolves by week 3.
- Injection site reactions: Rotate sites between abdomen, thigh, and upper arm each week. Minor redness or firmness is common and resolves within 24–48 hours.
- Caloric floor: Appetite suppression can cause under-eating. Maintain a minimum of 1,200–1,500 calories with adequate protein — losing lean mass alongside fat is a real risk that undermines the long-term metabolic outcome we are building.
Resistance Training: The Non-Negotiable Lever
GLP-1 medications induce weight loss that includes both fat and lean mass. Clinical data consistently shows that without resistance training, a meaningful portion of weight lost on GLP-1 therapy comes from muscle. Preserving lean mass is critical not just for aesthetics — muscle is metabolically active tissue that continues to improve insulin sensitivity, supports bone density, and is increasingly linked to cognitive resilience in aging men.
The 4M Muscle pillar (the second M) runs through all four months of the protocol. In month 1, the target is establishing a baseline: two to three resistance training sessions per week, compound movements (squat, hinge, press, pull), and sufficient protein to support muscle protein synthesis. You do not need to be training at high intensity in month 1. You need to be training consistently.